{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T18:03:25Z","timestamp":1790791405388,"version":"4.1.0"},"reference-count":143,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,10,6]],"date-time":"2022-10-06T00:00:00Z","timestamp":1665014400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100009702","name":"Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009702","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>\n                    The NLRP3 inflammasome is one of the NOD-like receptor family members with the most functional characterization and acts as a key player in innate immune system, participating in several physiological processes including, among others, the modulation of the immune system response and the coordination of host defences. Activation of the inflammasome is a crucial signaling mechanism that promotes both an acute and a chronic inflammatory response, which can accelerate the production of pro-inflammatory cytokines, mainly Interleukin (IL)-1\u03b2 and IL-18, leading to an exacerbated inflammatory network. Cryopyrin associated periodic syndrome (CAPS) is a rare inherited autoinflammatory disorder, clinically characterized by cutaneous and systemic, musculoskeletal, and central nervous system inflammation. Gain-of-function mutations in\n                    <jats:italic>NLRP3<\/jats:italic>\n                    gene are causative of signs and inflammatory symptoms in CAPS patients, in which an abnormal activation of the NLRP3 inflammasome, resulting in an inappropriate release of IL-1\u03b2 and gasdermin-D-dependent pyroptosis, has been demonstrated both in\n                    <jats:italic>in vitro<\/jats:italic>\n                    and in\n                    <jats:italic>ex vivo<\/jats:italic>\n                    studies. During recent years, two new hereditary NLRP3-related disorders have been described, deafness autosomal dominant 34 (DFN34) and keratitis fugax hereditaria (KFH), with an exclusive cochlear- and anterior eye- restricted autoinflammation, respectively, and caused by mutations in\n                    <jats:italic>NLRP3<\/jats:italic>\n                    gene, thus expanding the clinical and genetic spectrum of NLRP3-associated autoinflammatory diseases. Several crucial mechanisms involved in the control of activation and regulation of the NLRP3 inflammasome have been identified and researchers took advantage of this to develop novel target therapies with a significant improvement of clinical signs and symptoms of NLRP3-associated diseases. This review provides a broad overview of NLRP3 inflammasome biology with particular emphasis on CAPS, whose clinical, genetic, and therapeutic aspects will be explored in depth. The latest evidence on two \u201cnew\u201d diseases, DFN34 and KFH, caused by mutations in\n                    <jats:italic>NLRP3<\/jats:italic>\n                    is also described.\n                  <\/jats:p>","DOI":"10.3389\/fimmu.2022.1007705","type":"journal-article","created":{"date-parts":[[2022,10,6]],"date-time":"2022-10-06T02:41:56Z","timestamp":1665024116000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":66,"title":["NLRP3 inflammasome and NLRP3-related autoinflammatory diseases: From cryopyrin function to targeted therapies"],"prefix":"10.3389","volume":"13","author":[{"given":"Chiara","family":"Moltrasio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Romagnuolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelo Valerio","family":"Marzano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,10,6]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/s1097-2765(02)00599-3","article-title":"The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta","volume":"10","author":"Martinon","year":"2002","journal-title":"Mol Cell"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1038\/nature10759","article-title":"Inflammasomes in health and disease","volume":"481","author":"Strowig","year":"2012","journal-title":"Nature"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.02379","article-title":"Pattern recognition receptors and the host cell death molecular machinery","volume":"9","author":"Amarante-Mendes","year":"2018","journal-title":"Front Immunol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20133328","article-title":"The NLRP3 inflammasome: An overview of mechanisms of activation and regulation","volume":"20","author":"Kelley","year":"2019","journal-title":"Int J Mol Sci"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1002\/glia.22499","article-title":"Human astrocytes express a novel NLRP2 inflammasome","volume":"61","author":"Minkiewicz","year":"2013","journal-title":"Glia"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2011.04.022","article-title":"NLRP6 inflammasome regulates colonic microbial ecology and risk for colitis","volume":"145","author":"Elinav","year":"2011","journal-title":"Cell"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2012.02.001","article-title":"An NLRP7-containing inflammasome mediates recognition of microbial lipopeptides in human macrophages","volume":"36","author":"Khare","year":"2012","journal-title":"Immunity"},{"key":"B8","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.immuni.2012.07.006.","article-title":"The NLRP12 inflammasome recognizes yersinia pestis","volume":"37","author":"Vladimer","year":"2012","journal-title":"Immunity"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.chom.2011.04.008","article-title":"IFI16 acts as a nuclear pathogen sensor to induce the inflammasome in response to kaposi sarcoma-associated herpesvirus infection","volume":"9","author":"Kerur","year":"2011","journal-title":"Cell Host Microbe"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1038\/ni.2022","article-title":"Fatty acid-induced NLRP3-ASC inflammasome activation interferes with insulin signaling","volume":"12","author":"Wen","year":"2011","journal-title":"Nat Immunol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.csbj.2021.07.038","article-title":"From pyroptosis, apoptosis and necroptosis to PANoptosis: A mechanistic compendium of programmed cell death pathways","volume":"19","author":"Wang","year":"2021","journal-title":"Comput Struct Biotechnol J"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-019-00638-z","article-title":"CAPS and NLRP3","volume":"39","author":"Booshehri","year":"2019","journal-title":"J Clin Immunol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1007\/s11882-010-0160-9","article-title":"Cryopyrin-associated periodic syndrome: an update on diagnosis and treatment response","volume":"11","author":"Yu","year":"2011","journal-title":"Curr Allergy Asthma Rep"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1702946114","article-title":"NLRP3 mutation and cochlear autoinflammation cause syndromic and nonsyndromic hearing loss DFNA34 responsive to anakinra therapy","volume":"114","author":"Nakanishi","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B15","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.ajo.2018.01.017","article-title":"Keratoendotheliitis fugax hereditaria: A novel cryopyrin-associated periodic syndrome caused by a mutation in the nucleotide-binding domain, leucine-rich repeat family, pyrin domain-containing 3 (NLRP3) gene","volume":"188","author":"Turunen","year":"2018","journal-title":"Am J Ophthalmol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1038\/nrd.2018.149","article-title":"Targeting the NLRP3 inflammasome in inflammatory diseases","volume":"17","author":"Mangan","year":"2018","journal-title":"Nat Rev Drug Discov"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1007\/978-981-13-9367-9_6","article-title":"Structural biology of NOD-like receptors","volume":"1172","author":"Yang","year":"2019","journal-title":"Adv Exp Med Biol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1038\/nri.2016.58","article-title":"Inflammasomes: mechanism of assembly, regulation and signalling","volume":"16","author":"Broz","year":"2016","journal-title":"Nat Rev Immunol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1111\/myc.12711","article-title":"Overexpression of NLRP3, NLRC4 and AIM2 inflammasomes and their priming-associated molecules (TLR2, TLR4, dectin-1, dectin-2 and NF\u03baB) in malassezia folliculitis","volume":"61","author":"Liang","year":"2018","journal-title":"Mycoses"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0901363","article-title":"Cutting edge: NF-kappaB activating pattern recognition and cytokine receptors license NLRP3 inflammasome activation by regulating NLRP3 expression","volume":"183","author":"Bauernfeind","year":"2009","journal-title":"J Immunol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1302839","article-title":"FADD and caspase-8 mediate priming and activation of the canonical and noncanonical Nlrp3 inflammasomes","volume":"192","author":"Gurung","year":"2014","journal-title":"J Immunol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.15252\/embr.201438463","article-title":"Mitochondrial apoptosis is dispensable for NLRP3 inflammasome activation but non-apoptotic caspase-8 is required for inflammasome priming","volume":"15","author":"Allam","year":"2014","journal-title":"EMBO Rep"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1038\/cmi.2015.95","article-title":"Molecular mechanisms regulating NLRP3 inflammasome activation","volume":"13","author":"Jo","year":"2016","journal-title":"Cell Mol Immunol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.tips.2022.04.003","article-title":"NLRP3 and pyroptosis blockers for treating inflammatory diseases","volume":"43","author":"Coll","year":"2022","journal-title":"Trends Pharmacol Sci"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.00036","article-title":"Canonical and non-canonical activation of NLRP3 inflammasome at the crossroad between immune tolerance and intestinal inflammation","volume":"8","author":"Pellegrini","year":"2017","journal-title":"Front Immunol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1038\/nature04515","article-title":"Cryopyrin activates the inflammasome in response to toxins and ATP","volume":"440","author":"Mariathasan","year":"2006","journal-title":"Nature"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1038\/ni.1631","article-title":"Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization","volume":"9","author":"Hornung","year":"2008","journal-title":"Nat Immunol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1412487111","article-title":"Human NLRP3 inflammasome senses multiple types of bacterial RNAs","volume":"111","author":"Sha","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1038\/nature04517","article-title":"Bacterial RNA and small antiviral compounds activate caspase-1 through cryopyrin\/Nalp3","volume":"440","author":"Kanneganti","year":"2006","journal-title":"Nature"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2015.00570","article-title":"Bacterial exotoxins and the inflammasome","volume":"6","author":"Greaney","year":"2015","journal-title":"Front Immunol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"3328","DOI":"10.3390\/ijms2013332","article-title":"The NLRP3 inflammasome: An overview of mechanisms of activation and regulation","volume":"20","author":"Kelley","year":"2019","journal-title":"Int J Mol Sci"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2013.05.016","article-title":"K+ efflux is the common trigger of NLRP3 inflammasome activation by bacterial toxins and particulate matter","volume":"38","author":"Mu\u00f1oz-Planillo","year":"2013","journal-title":"Immunity"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1038\/nature16959","article-title":"NEK7 is an essential mediator of NLRP3 activation downstream of potassium efflux","volume":"530","author":"He","year":"2016","journal-title":"Nature"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1038\/s41422-020-0295-8","article-title":"Toward targeting inflammasomes: insights into their regulation and activation","volume":"30","author":"Christgen","year":"2020","journal-title":"Cell Res"},{"key":"B35","doi-asserted-by":"publisher","first-page":"e2015632118","DOI":"10.1073\/pnas.2015632118","article-title":"Ratsimandresy RA, carriere J, andres AM et\u00a0al. recruitment of pro-IL-1\u03b1 to mitochondrial cardiolipin, via shared LC3 binding domain, inhibits mitophagy and drives maximal NLRP3 activation","volume":"118","author":"Dagvadorj","year":"2021","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B36","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1002\/bab.1700","article-title":"Role and mechanism of ROS scavengers in alleviating NLRP3-mediated inflammation","volume":"66","author":"Sho","year":"2019","journal-title":"Biotechnol Appl Biochem"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1038\/nri2725","article-title":"NLRP3 inflammasome activation: The convergence of multiple signalling pathways on ROS production","volume":"10","author":"Tschopp","year":"2010","journal-title":"Nat Rev Immunol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1002\/eji.200940185","article-title":"Critical functions of priming and lysosomal damage for NLRP3 activation","volume":"40","author":"Hornung","year":"2010","journal-title":"Eur J Immunol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1038\/cmi.2016.29","article-title":"Post-translational regulation of inflammasomes","volume":"14","author":"Yang","year":"2017","journal-title":"Cell Mol Immunol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20160933","article-title":"NLRP3 inflammasome assembly is regulated by phosphorylation of the pyrin domain","volume":"214","author":"Stutz","year":"2017","journal-title":"J Exp Med"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.abe3410","article-title":"Tyrosine phosphorylation of NLRP3 by the src family kinase Lyn suppresses the activity of the NLRP3 inflammasome","volume":"14","author":"Tang","year":"2021","journal-title":"Sci Signal"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.2000649","article-title":"AKT regulates NLRP3 inflammasome activation by phosphorylating NLRP3 serine 5","volume":"205","author":"Zhao","year":"2020","journal-title":"J\u00a0Immunol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1172\/JCI83669.","article-title":"NLRP3 tyrosine phosphorylation is controlled by protein tyrosine phosphatase PTPN22","volume":"126","author":"Spalinger","year":"2016","journal-title":"J Clin Invest"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2017.08.017","article-title":"NLRP3 phosphorylation is an essential priming event for inflammasome activation","volume":"68","author":"Song","year":"2017","journal-title":"Mol Cell"},{"key":"B45","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.cell.2014.11.047","article-title":"Dopamine controls systemic inflammation through inhibition of NLRP3 inflammasome","volume":"160","author":"Yan","year":"2015","journal-title":"Cell"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms13727","article-title":"The E3 ubiquitin ligase TRIM31 attenuates NLRP3 inflammasome activation by promoting proteasomal degradation of NLRP3","volume":"7","author":"Song","year":"2016","journal-title":"Nat Commun"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2012.11.009","article-title":"Deubiquitination of NLRP3 by BRCC3 critically regulates inflammasome activity","volume":"49","author":"Py","year":"2013","journal-title":"Mol Cell"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20162040.49","article-title":"Protein kinase d at the golgi controls NLRP3 inflammasome activation","volume":"214","author":"Zhang","year":"2017","journal-title":"J Exp Med"},{"key":"B49","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s12964-020-00688-6","article-title":"Inflammasome activation controlled by the interplay between post-translational modifications: emerging drug target opportunities","volume":"19","author":"Liang","year":"2021","journal-title":"Cell Commun Signal"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.2100734","article-title":"Regulation of the NLRP3 inflammasome by posttranslational modifications","volume":"208","author":"Zangiabadi","year":"2022","journal-title":"J Immunol"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1016\/j.smim.2013.10.001","article-title":"Overview of the interleukin-1 family of ligands and receptors","volume":"25","author":"Dinarello","year":"2013","journal-title":"Semin Immunol"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-008-9178-3","article-title":"Diagnosis and management of autoinflammatory diseases in childhood","volume":"28","author":"Gattorno","year":"2008","journal-title":"J Clin Immunol"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2010.138420","article-title":"French CAPS study group. mutations in the autoinflammatory cryopyrin-associated periodic syndrome gene: epidemiological study and lessons from eight years of genetic analysis in France","volume":"70","author":"Cuisset","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1055\/s-0030-1265181","article-title":"Analysis of cryopyrin-associated periodic syndromes (CAPS) in German children: epidemiological, clinical and genetic characteristics","volume":"222","author":"Lainka","year":"2010","journal-title":"Klin Padiatr"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2017-212515","article-title":"et al; paediatric rheumatology international trials organisation (PRINTO) and the AIDs Delphi study participants. consensus proposal for taxonomy and definition of the autoinflammatory diseases (AIDs): a Delphi study","volume":"77","author":"Ben-Chetrit","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1940.62810120003010b","article-title":"A case of cold urticaria with an unusual family history","volume":"114","author":"Kile","year":"1940","journal-title":"J\u00a0Am Med Assoc"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2230.1993.tb02212.x","article-title":"Familial cold urticaria","volume":"18","author":"Zip","year":"1993","journal-title":"Clin Exp Dermatol"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1086\/302874","article-title":"Identification of a locus on chromosome 1q44 for familial cold urticaria","volume":"66","author":"Hoffman","year":"2000","journal-title":"Am J Hum Genet"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1038\/ng756","article-title":"Mutation of a new gene encoding a putative pyrin-like protein causes familial cold autoinflammatory syndrome and muckle-wells syndrome","volume":"29","author":"Hoffman","year":"2001","journal-title":"Nat Genet"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1067\/mai.2001.118790","article-title":"Familial cold autoinflammatory syndrome: phenotype and genotype of an autosomal dominant periodic fever","volume":"108","author":"Hoffman","year":"2001","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1186\/s12969-022-00669-8","article-title":"NLRP12-associated systemic autoinflammatory diseases in children","volume":"20","author":"Wang","year":"2022","journal-title":"Pediatr Rheumatol Online J"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1102140.54","article-title":"Cold urticaria, immunodeficiency, and autoimmunity related to PLCG2 deletions","volume":"366","author":"Ombrello","year":"2012","journal-title":"N Engl J Med"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20141091","article-title":"An inherited mutation in NLRC4 causes autoinflammation in human and mice","volume":"211","author":"Kitamura","year":"2014","journal-title":"J Exp Med"},{"key":"B64","article-title":"Urticaria, deafness, and amyloidosis: a new heredo-familial syndrome","volume":"31","author":"Muckle","year":"1962","journal-title":"Q J Med"},{"key":"B65","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1111\/j.1365-2133.1979.tb03572.x","article-title":"The \u2018Muckle-wells\u2019 syndrome","volume":"100","author":"Muckle","year":"1979","journal-title":"Br J Dermatol"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1086\/302589","article-title":"Genetic linkage of the muckle-wells syndrome to chromosome 1q44","volume":"65","author":"Cuisset","year":"1999","journal-title":"Am J Hum Genet"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-020-04683-5","article-title":"Novel mutation in the NRLP3 manifesting as an intermediate phenotype of cryopyrinopathies","volume":"41","author":"Paim-Marques","year":"2021","journal-title":"Rheumatol Int"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1007\/s12519-020-00358-0","article-title":"Muckle-wells syndrome: manifestations and diagnosis in four generations of a Portuguese family","volume":"16","author":"Azevedo","year":"2020","journal-title":"World J Pediatr"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-015-2920-3","article-title":"The protean ocular involvement in monogenic autoinflammatory diseases: state of the art","volume":"34","author":"Bascherini","year":"2015","journal-title":"Clin Rheumatol"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.142.12.1591","article-title":"Phenotype, genotype, and sustained response to anakinra in 22 patients with autoinflammatory disease associated with CIAS-1\/NALP3 mutations","volume":"142","author":"Leslie","year":"2006","journal-title":"Arch Dermatol"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(200009)43:9<2034","article-title":"An autosomal dominant periodic fever associated with AA amyloidosis in a north Indian family maps to distal chromosome 1q","volume":"43","author":"McDermott","year":"2000","journal-title":"Arthritis Rheumatol"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1002\/art.37827","article-title":"AA Amyloidosis complicating the hereditary periodic fever syndromes","volume":"65","author":"Lane","year":"2013","journal-title":"Arthritis Rheumatol"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2012.09.009","article-title":"Long-term efficacy and safety profile of rilonacept in the treatment of cryopryin-associated periodic syndromes: results of a 72-week open-label extension study","volume":"34","author":"Hoffman","year":"2012","journal-title":"Clin Ther"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keac145","article-title":"AA Amyloidosis complicating cryopyrin-associated periodic syndrome: a study on 86 cases including 23 French patients and systematic review","author":"Rodrigues","year":"2022","journal-title":"Rheumatol (Oxford)"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1159\/000099311","article-title":"A novel missense mutation in CIAS1 encoding the pyrin-like protein, cryopyrin, causes familial cold autoinflammatory syndrome in a family of Ethiopian origin","volume":"143","author":"Shalev","year":"2007","journal-title":"Int Arch Allergy Immunol"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0810787","article-title":"Canakinumab in CAPS study group. use of canakinumab in the cryopyrin-associated periodic syndrome","volume":"360","author":"Lachmann","year":"2009","journal-title":"N Engl J Med"},{"key":"B77","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1186\/s13023-016-0542-8","article-title":"Chronic infantile neurological cutaneous and articular (CINCA) syndrome: a review","volume":"11","author":"Finetti","year":"2016","journal-title":"Orphanet J Rare Dis"},{"key":"B78","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/s0022-3476(81)80961-4","article-title":"Arthropathy with rash, chronic meningitis, eye lesions, and mental retardation","volume":"99","author":"Prieur","year":"1981","journal-title":"J Pediatr"},{"key":"B79","doi-asserted-by":"publisher","first-page":"57","DOI":"10.3109\/03009748709102523","article-title":"A chronic, infantile, neurological, cutaneous and articular (CINCA) syndrome. a specific entity analysed in 30 patients","volume":"66","author":"Prieur","year":"1987","journal-title":"Scand J Rheumatol Suppl"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1007\/BF00361425","article-title":"NOMID\u2013a neonatal syndrome of multisystem inflammation","volume":"18","author":"Torbiak","year":"1989","journal-title":"Skeletal Radiol"},{"key":"B81","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1086\/341357","article-title":"Chronic infantile neurological cutaneous and articular syndrome is caused by mutations in CIAS1, a gene highly expressed in polymorphonuclear cells and chondrocytes","volume":"71","author":"Feldmann","year":"2002","journal-title":"Am J Hum Genet"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1002\/art.10688","article-title":"De novo CIAS1 mutations, cytokine activation, and evidence for genetic heterogeneity in patients with neonatal-onset multisystem inflammatory disease (NOMID): a new member of the expanding family of pyrin-associated autoinflammatory diseases","volume":"46","author":"Aksentijevich","year":"2002","journal-title":"Arthritis Rheumatol"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.170041","article-title":"Cryopyrin-associated periodic syndromes in Italian patients: Evaluation of the rate of somatic NLRP3 mosaicism and phenotypic characterization","volume":"44","author":"Lasigli\u00e8","year":"2017","journal-title":"J Rheumatol"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2013-204991","article-title":"For PRINTO and eurofever. phenotypic and genotypic characteristics of cryopyrin-associated periodic syndrome: a series of 136 patients from the eurofever registry","volume":"74","author":"Levy","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpn.2019.03.006","article-title":"S. spectrum of the neurologic manifestations in childhood-onset cryopyrin-associated periodic syndrome","volume":"23","author":"Kilic","year":"2019","journal-title":"Eur J Paediatr Neurol"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.118.10.1386","article-title":"Chronic infantile neurological cutaneous and articular\/neonatal onset multisystem inflammatory disease syndrome: ocular manifestations in a recently recognized chronic inflammatory disease of childhood","volume":"118","author":"Dollfus","year":"2000","journal-title":"Arch Ophthalmol"},{"key":"B87","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1177\/0194599811402296","article-title":"Cryopyrin-associated periodic syndromes: otolaryngologic and audiologic manifestations","volume":"145","author":"Ahmadi","year":"2011","journal-title":"Otolaryngol Head Neck Surg"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1007\/s00247-006-0358-0","article-title":"Arthropathy of neonatal onset multisystem inflammatory disease (NOMID\/CINCA)","volume":"37","author":"Hill","year":"2007","journal-title":"Pediatr Radiol"},{"key":"B89","unstructured":"Infevers, online database"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/2023119","article-title":"Identification of a new variant in NLRP3 gene by whole exome sequencing in a patient with cryopyrin-associated periodic syndrome","volume":"2021","author":"Vahedi","year":"2021","journal-title":"Case Rep Immunol"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1016\/s1074-7613(04)00046-9","article-title":"NALP3 forms an IL-1beta-processing inflammasome with increased activity in muckle-wells autoinflammatory disorder","volume":"20","author":"Agostini","year":"2004","journal-title":"Immunity"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-07-2531","article-title":"Molecular basis of the spectral expression of CIAS1 mutations associated with phagocytic cell-mediated autoinflammatory disorders CINCA\/NOMID, MWS, and FCU","volume":"103","author":"Neven","year":"2004","journal-title":"Blood"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1038\/sj.cdd.4401734","article-title":"Cryopyrin and pyrin activate caspase-1, but not NF-kappaB, via ASC oligomerization","volume":"13","author":"Yu","year":"2006","journal-title":"Cell Death Differ"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M401178200","article-title":"Cryopyrin-induced interleukin 1beta secretion in monocytic cells: enhanced activity of disease-associated mutants and requirement for ASC","volume":"279","author":"Dowds","year":"2004","journal-title":"J Biol Chem"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1000779107","article-title":"Altered redox state of monocytes from cryopyrin-associated periodic syndromes causes accelerated IL-1beta secretion","volume":"107","author":"Tassi","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2006.12.649","article-title":"Monocytes from familial cold autoinflammatory syndrome patients are activated by mild hypothermia","volume":"119","author":"Rosengren","year":"2007","journal-title":"J Allergy Clin Immunol"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.75166","article-title":"Cryo-sensitive aggregation triggers NLRP3 inflammasome assembly in cryopyrin-associated periodic syndrome","volume":"11","author":"Karasawa","year":"2022","journal-title":"Elife"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2009.05.005","article-title":"Inflammasome-mediated disease animal models reveal roles for innate but not adaptive immunity","volume":"30","author":"Brydges","year":"2009","journal-title":"Immunity"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2009.04.012","article-title":"A mutation in the Nlrp3 gene causing inflammasome hyperactivation potentiates Th17 cell-dominant immune responses","volume":"30","author":"Meng","year":"2009","journal-title":"Immunity"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1038\/ni.2919.101","article-title":"The NLRP3 inflammasome is released as a particulate danger signal that amplifies the inflammatory response","volume":"15","author":"Baroja-Mazo","year":"2014","journal-title":"Nat Immunol"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.3000047","article-title":"Gasdermin d mediates the pathogenesis of neonatal-onset multisystem inflammatory disease in mice","volume":"16","author":"Xiao","year":"2018","journal-title":"PloS Biol"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1002\/art.21404","article-title":"Somatic mosaicism of CIAS1 in a patient with chronic infantile neurologic, cutaneous, articular syndrome","volume":"52","author":"Saito","year":"2005","journal-title":"Arthritis Rheumatol"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1002\/art.30512","article-title":"High incidence of NLRP3 somatic mosaicism in patients with chronic infantile neurologic, cutaneous, articular syndrome: results of an international multicenter collaborative study","volume":"63","author":"Tanaka","year":"2011","journal-title":"Arthritis Rheumatol"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1080\/10408363.2018.1488805","article-title":"Mosaicism in autoinflammatory diseases: Cryopyrin-associated periodic syndromes (CAPS) and beyond. a systematic review","volume":"55","author":"Labrousse","year":"2018","journal-title":"Crit Rev Clin Lab Sci"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.01410","article-title":"Late-onset cryopyrin-associated periodic syndromes caused by somatic NLRP3 mosaicism-UK single center experience","volume":"8","author":"Rowczenio","year":"2017","journal-title":"Front Immunol"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2019.11.035","article-title":"NLRP3-associated autoinflammatory diseases: Phenotypic and molecular characteristics of germline versus somatic mutations","volume":"145","author":"Louvrier","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1002\/art.40208","article-title":"Clinical and molecular phenotypes of low-penetrance variants of NLRP3: Diagnostic and therapeutic challenges","volume":"69","author":"Kuemmerle-Deschner","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keaa511","article-title":"Otological aspects of NLRP3-related autoinflammatory disorder focusing on the responsiveness to anakinra","volume":"60","author":"Kim","year":"2021","journal-title":"Rheumatol (Oxford)"},{"key":"B109","article-title":"Keratoendotheliitis fugax hereditaria","volume-title":"StatPearls","author":"Moshirfar","year":"2022"},{"key":"B110","article-title":"Keratitis fugax hereditaria [Keratitis fugax hereditaria]","volume":"80","author":"Valle","year":"1964","journal-title":"Duodecim"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1111\/j.1755-3768.1987.tb06995.x","article-title":"Keratoendotheliitis fugax hereditaria. a clinical and specular microscopic study of a family with dominant inflammatory corneal disease","volume":"65","author":"Ruusuvaara","year":"1987","journal-title":"Acta Ophthalmol (Copenh)"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2020.02.002","article-title":"In vivo corneal confocal microscopy and histopathology of keratitis fugax hereditaria from a pathogenic variant in NLRP3","volume":"213","author":"Turunen","year":"2020","journal-title":"Am J Ophthalmol"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2021.10.025","article-title":"Clinical spectrum and geographic distribution of keratitis fugax hereditaria caused by the pathogenic variant c.61G>C in NLRP3","volume":"236","author":"Immonen","year":"2022","journal-title":"Am J Ophthalmol"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2020-001227","article-title":"Systematic literature review of efficacy\/effectiveness and safety of current therapies for the treatment of cryopyrin-associated periodic syndrome, hyperimmunoglobulin d syndrome and tumour necrosis factor receptor-associated periodic syndrome","volume":"6","author":"Kuemmerle-Deschner","year":"2020","journal-title":"RMD Open"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.619257","article-title":"IL-1 inhibitors in the treatment of monogenic periodic fever syndromes: From the past to the future perspectives","volume":"11","author":"Malcova","year":"2021","journal-title":"Front Immunol"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa055137","article-title":"Neonatal-onset multisystem inflammatory disease responsive to interleukin-1beta inhibition","volume":"355","author":"Goldbach-Mansky","year":"2006","journal-title":"N Engl J Med"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.1002\/art.34409","article-title":"Sustained response and prevention of damage progression in patients with neonatal-onset multisystem inflammatory disease treated with anakinra: a cohort study to determine three- and five-year outcomes","volume":"64","author":"Sibley","year":"2012","journal-title":"Arthritis Rheumatol"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1002\/art.23620","article-title":"A pilot study to evaluate the safety and efficacy of the long-acting interleukin-1 inhibitor rilonacept (interleukin-1 trap) in patients with familial cold autoinflammatory syndrome","volume":"58","author":"Goldbach-Mansky","year":"2008","journal-title":"Arthritis Rheumatol"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2011.152728","article-title":"Two-year results from an open-label, multicentre, phase III study evaluating the safety and efficacy of canakinumab in patients with cryopyrin-associated periodic syndrome across different severity phenotypes","volume":"70","author":"Kuemmerle-Deschner","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/2898553","article-title":"The efficacy of anti-tumor necrosis factor therapy in cryopyrin-associated periodic syndromes: A report of two cases","volume":"2022","author":"Tahghighi","year":"2022","journal-title":"Case Rep Genet"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1172\/JCI98322","article-title":"Confounding role of tumor necrosis factor in cryopyrin-associated periodic syndromes","volume":"127","author":"Banoth","year":"2017","journal-title":"J Clin Invest"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.919973","article-title":"Interleukin-18 cytokine in immunity, inflammation, and autoimmunity: Biological role in induction, regulation, and treatment","volume":"13","author":"Ihim","year":"2022","journal-title":"Front Immunol"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.02538","article-title":"Pharmacological inhibitors of the NLRP3 inflammasome","volume":"10","author":"Zahid","year":"2019","journal-title":"Front Immunol"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.150962.","article-title":"Clinical characteristics of patients carrying the Q703K variant of the NLRP3 gene: A 10-year multicentric national study","volume":"43","author":"Naselli","year":"2016","journal-title":"J Rheumatol"},{"key":"B125","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.autrev.2015.08.008","article-title":"Clinical and genetic characterization of the autoinflammatory diseases diagnosed in an adult reference center","volume":"15","author":"Hern\u00e1ndez-Rodr\u00edguez","year":"2016","journal-title":"Autoimmun Rev"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.1002\/art.38811","article-title":"Anakinra use during pregnancy in patients with cryopyrin-associated periodic syndromes (CAPS)","volume":"66","author":"Chang","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"B127","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2147\/jir.s8109","article-title":"Rilonacept in the management of cryopyrin-associated periodic syndromes (CAPS)","volume":"3","author":"Gillespie","year":"2010","journal-title":"J Inflammation Res"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.1002\/art.23687","article-title":"Efficacy and safety of rilonacept (interleukin-1 trap) in patients with cryopyrin-associated periodic syndromes: results from two sequential placebo-controlled studies","volume":"58","author":"Hoffman","year":"2008","journal-title":"Arthritis Rheumatol"},{"key":"B129","doi-asserted-by":"publisher","first-page":"R202","DOI":"10.1186\/ar3535","article-title":"Canakinumab in CAPS study group. sustained remission of symptoms and improved health-related quality of life in patients with cryopyrin-associated periodic syndrome treated with canakinumab: results of a double-blind placebo-controlled randomized withdrawal study","volume":"13","author":"Kon\u00e9-Paut","year":"2011","journal-title":"Arthritis Res Ther"},{"key":"B130","first-page":"19","article-title":"Long-term safety and efficacy of canakinumab in cryopyrin-associated periodic syndrome: results from an open-label, phase III pivotal study in Japanese patients","author":"Yokota","year":"2017","journal-title":"Clin Exp Rheumatol"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2013-204877","article-title":"A 24-month open-label study of canakinumab in neonatal-onset multisystem inflammatory disease","volume":"74","author":"Sibley","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/ket415","article-title":"Efficacy and safety of canakinumab therapy in paediatric patients with cryopyrin-associated periodic syndrome: a single-centre, real-world experience","volume":"53","author":"Russo","year":"2014","journal-title":"Rheumatol (Oxford)"},{"key":"B133","doi-asserted-by":"publisher","first-page":"R196","DOI":"10.1186\/ar3526","article-title":"NLRP3 E311K mutation in a large family with muckle-wells syndrome\u2013description of a heterogeneous phenotype and response to treatment","volume":"13","author":"Kuemmerle-Deschner","year":"2011","journal-title":"Arthritis Res Ther"},{"key":"B134","doi-asserted-by":"publisher","first-page":"R64","DOI":"10.1186\/ar4237","article-title":"Treatment of muckle-wells syndrome: analysis of two IL-1-blocking regimens","volume":"15","author":"Kuemmerle-Deschner","year":"2013","journal-title":"Arthritis Res Ther"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2022.865763","article-title":"Auditory and vestibular characteristics of NLRP3 inflammasome related autoinflammatory disorders: Monogenic hearing loss can be improved by anti-interleukin-1 therapy","volume":"13","author":"Nakanishi","year":"2022","journal-title":"Front Neurol"},{"key":"B136","doi-asserted-by":"publisher","first-page":"e8689","DOI":"10.15252\/emmm.201708689","article-title":"Tranilast directly targets NLRP3 to treat inflammasome-driven diseases","volume":"10","author":"Huang","year":"2018","journal-title":"EMBO Mol Med"},{"key":"B137","unstructured":"ClinicalTrials.gov, database"},{"key":"B138","unstructured":"ClinicalTrials.gov, database"},{"key":"B139","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3804","article-title":"The ketone metabolite \u03b2-hydroxybutyrate blocks NLRP3 inflammasome-mediated inflammatory disease","volume":"21","author":"Youm","year":"2015","journal-title":"Nat Med"},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3806","article-title":"A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases","volume":"21","author":"Coll","year":"2015","journal-title":"Nat Med"},{"key":"B141","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2022.108595","article-title":"MCC950 in the treatment of NLRP3-mediated inflammatory diseases: Latest evidence and therapeutic outcomes","volume":"106","author":"Bakhshi","year":"2022","journal-title":"Int Immunopharmacol"},{"key":"B142","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1716095115","article-title":"OLT1177, a \u03b2-sulfonyl nitrile compound, safe in humans, inhibits the NLRP3 inflammasome and reverses the metabolic cost of inflammation","volume":"115","author":"Marchetti","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B143","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2019.05.034","article-title":"A novel knock-in mouse model of cryopyrin-associated periodic syndromes with development of amyloidosis: Therapeutic efficacy of proton pump inhibitors","volume":"145","author":"Bertoni","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.1007705\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,6]],"date-time":"2022-10-06T02:42:02Z","timestamp":1665024122000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.1007705\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,6]]},"references-count":143,"alternative-id":["10.3389\/fimmu.2022.1007705"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2022.1007705","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,6]]},"article-number":"1007705"}}